María Obdulia
Rabal Gracia
Investigadora hasta 2019
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2020
-
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
Cancer Letters, Vol. 468, pp. 1-13
2019
-
MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes
Translational Stroke Research, Vol. 10, Núm. 4, pp. 389-401
2018
-
Phenotypic Screening to Discover Novel Chemical Series as Efficient Antihemorrhagic Agents
ACS Medicinal Chemistry Letters, Vol. 9, Núm. 5, pp. 428-433